RAVENQUEST BIOMED ORD SHS Receivables

RAVENQUEST BIOMED ORD SHS posts a receivables of $920K as of July 2019. That compares with $1.5M in the prior-year period — down 40.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, RAVENQUEST BIOMED ORD SHS's receivables was $1.5M. The latest reading is $920K — a 40.2% year-over-year decrease (period ending July 2019). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of RAVENQUEST BIOMED ORD SHS's financial statement story. At $920K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RVVQF's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; RAVENQUEST BIOMED ORD SHS's other metric pages and overview cover the third.